Versus Systems regains equity compliance but receives new deficiency for missing 2024 annual meeting

Versus Systems Inc.

Completed sale of 2,155,172 shares and warrants for 1,077,586 shares upon conversion of $2.5M note on Dec 23, 2024; equity now meets Nasdaq Rule 5550(b)(1).
Nasdaq will continue monitoring; delisting possible if not evidenced at next periodic report.
Jan 6, 2025 Nasdaq deficiency for failure to hold 2024 annual meeting; must submit compliance plan by Feb 20, 2025.
Company expects combined 2024/2025 annual meeting in Q2 2025 to regain compliance.
Second deficiency has no immediate effect on listing of VS or VSSYW on Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.